Skip to main content
Top
Published in: Pediatric Rheumatology 1/2021

Open Access 01-12-2021 | Magnetic Resonance Imaging | Research article

Assessment of disease activity using a whole-body MRI derived radiological activity index in chronic nonbacterial osteomyelitis

Authors: Martina Capponi, Denise Pires Marafon, Flaminia Rivosecchi, Yongdong Zhao, Manuela Pardeo, Virginia Messia, Laura Tanturri de Horatio, Paolo Tomà, Fabrizio De Benedetti, Antonella Insalaco

Published in: Pediatric Rheumatology | Issue 1/2021

Login to get access

Abstract

Background

Based on the recently developed ChRonic nonbacterial Osteomyelitis MRI Scoring tool (CROMRIS), we developed a radiological activity index (RAI-CROMRIS) to obtain a quantification of the overall bone involvement in individual patients.

Methods

Whole Body Magnetic Resonance Imaging (WB-MRI) images were scored according to parameters included in the RAI-CROMRIS: bone marrow hyperintensity, signal extension, soft tissue/periosteal hyperintensity, bony expansion, vertebral collapse. These parameters were evaluated for each bone unit yielding a score from 0 to 7 and summed up as RAI-CROMRIS including all bone units. We assessed clinical disease activity using a physician global assessment (PGA) and radiological findings in 76 treatment-naïve patients; 46 of 76 were evaluated at 6 and 12 months after initial WB-MRI. Quantitative variables were compared using the Mann-Whitney U test for unmatched groups and the Wilcoxon signed-rank test for paired groups. Correlation was evaluated using Spearman’s rank coefficient (rs).

Results

There was a significant correlation between RAI-CROMRIS and PGA (rs = 0.32; p = 0.0055), between RAI-CROMRIS and presence of elevated erythrocyte sedimentation rate (p = 0.013) and C-reactive protein (p = 0.0001) at baseline. The RAI-CROMRIS decreased from a median of 17 at baseline to 12 at 6 months (p = 0.004) and remained stable (median 11) at 12 months. A correlation between the RAI-CROMRIS and the PGA was observed at baseline (rs = 0.41; p = 0.004) and during follow up at 6 months (rs = 0.33; p = 0.025) and 12 months (rs = 0.38; p = 0.010). The baseline RAI-CROMRIS (median 20) was significantly higher in patients who subsequently received bisphosphonates than in patients who received other treatments (median 12) and decreased significantly after bisphosphonates (p = 0.008).

Conclusions

The RAI-CROMRIS was correlated with clinical and laboratory measures of disease activity showing significant short-term changes following treatment with bisphosphonates. This tool could be used in clinical practice and clinical trials after validation.
Appendix
Available only for authorised users
Literature
3.
go back to reference Giedion A, Holthusen W, Masel LF, Vischer D. Subacute and chronic “symmetrical” osteomyelitis. Ann Radiol. 1972;15:329–42.PubMed Giedion A, Holthusen W, Masel LF, Vischer D. Subacute and chronic “symmetrical” osteomyelitis. Ann Radiol. 1972;15:329–42.PubMed
21.
go back to reference Mandell GA, Contreras SJ, Conard K, Harcke HT, Maas KW. Bone scintigraphy in the detection of chronic recurrent multifocal osteomyelitis. J Nucl Med. 1998;39(10):1778–83.PubMed Mandell GA, Contreras SJ, Conard K, Harcke HT, Maas KW. Bone scintigraphy in the detection of chronic recurrent multifocal osteomyelitis. J Nucl Med. 1998;39(10):1778–83.PubMed
27.
go back to reference Swinscow TDV. Statistics at square one, ninth edition, revised by MJ Campbell. Southampton: John Mark Ockerbloom; 1997. Swinscow TDV. Statistics at square one, ninth edition, revised by MJ Campbell. Southampton: John Mark Ockerbloom; 1997.
28.
go back to reference Zhao Y, Wu EY, Oliver MS, Cooper AM, Basiaga ML, Vora SS, et al. Consensus treatment plans for chronic nonbacterial osteomyelitis refractory to nonsteroidal antiinflammatory drugs and/or with active spinal lesions. Arthritis Care Res. 2018;70(8):1228–37. https://doi.org/10.1002/acr.23462.CrossRef Zhao Y, Wu EY, Oliver MS, Cooper AM, Basiaga ML, Vora SS, et al. Consensus treatment plans for chronic nonbacterial osteomyelitis refractory to nonsteroidal antiinflammatory drugs and/or with active spinal lesions. Arthritis Care Res. 2018;70(8):1228–37. https://​doi.​org/​10.​1002/​acr.​23462.CrossRef
37.
go back to reference Gleeson H, Wiltshire E, Briody J, Hall J, Chaitow J, Sillence D, et al. Childhood chronic recurrent multifocal osteomyelitis: pamidronate therapy decreases pain and improves vertebral shape. J Rheumatol. 2008;35:707 PMID: 18381777.PubMed Gleeson H, Wiltshire E, Briody J, Hall J, Chaitow J, Sillence D, et al. Childhood chronic recurrent multifocal osteomyelitis: pamidronate therapy decreases pain and improves vertebral shape. J Rheumatol. 2008;35:707 PMID: 18381777.PubMed
39.
go back to reference Lil-Sofie MO. Establishment of normative MRI standards for the paediatric skeleton to better outline pathology. Focused on juvenile idiopathic arthritis. A dissertation for the degree of philosophiae doctor. Tromsø: University of Tromsø, Faculty of Health Sciences; 2012. Lil-Sofie MO. Establishment of normative MRI standards for the paediatric skeleton to better outline pathology. Focused on juvenile idiopathic arthritis. A dissertation for the degree of philosophiae doctor. Tromsø: University of Tromsø, Faculty of Health Sciences; 2012.
Metadata
Title
Assessment of disease activity using a whole-body MRI derived radiological activity index in chronic nonbacterial osteomyelitis
Authors
Martina Capponi
Denise Pires Marafon
Flaminia Rivosecchi
Yongdong Zhao
Manuela Pardeo
Virginia Messia
Laura Tanturri de Horatio
Paolo Tomà
Fabrizio De Benedetti
Antonella Insalaco
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue 1/2021
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/s12969-021-00620-3

Other articles of this Issue 1/2021

Pediatric Rheumatology 1/2021 Go to the issue